{"id":25782,"date":"2022-11-22T06:01:31","date_gmt":"2022-11-22T06:01:31","guid":{"rendered":"https:\/\/www.curiumpharma.com\/?p=25782"},"modified":"2023-01-09T15:31:28","modified_gmt":"2023-01-09T15:31:28","slug":"new-indication-ioflupane","status":"publish","type":"post","link":"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/","title":{"rendered":"Curium Announces New Indication for Ioflupane I 123 Injection in the U.S."},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"author":89,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[96],"tags":[],"class_list":["post-25782","post","type-post","status-publish","format-standard","hentry","category-press-releases-it"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Curium Announces New Indication for Ioflupane I 123 Injection in the U.S. - Curium Pharma<\/title>\n<meta name=\"description\" content=\"Curium intends to submit updated labeling to the FDA for its generic version of DaTscan\u2122 (Ioflupane I 123 Injection) to include a new indication and updated safety information.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Curium Announces New Indication for Ioflupane I 123 Injection in the U.S. - Curium Pharma\" \/>\n<meta property=\"og:description\" content=\"Curium intends to submit updated labeling to the FDA for its generic version of DaTscan\u2122 (Ioflupane I 123 Injection) to include a new indication and updated safety information.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/\" \/>\n<meta property=\"og:site_name\" content=\"Curium Pharma\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T06:01:31+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-01-09T15:31:28+00:00\" \/>\n<meta name=\"author\" content=\"Elisabeth Baucells\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Elisabeth Baucells\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/it\\\/2022\\\/11\\\/22\\\/new-indication-ioflupane\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/it\\\/2022\\\/11\\\/22\\\/new-indication-ioflupane\\\/\"},\"author\":{\"name\":\"Elisabeth Baucells\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#\\\/schema\\\/person\\\/e4f8faf9cb0b0abf9a175f21afe353c6\"},\"headline\":\"Curium Announces New Indication for Ioflupane I 123 Injection in the U.S.\",\"datePublished\":\"2022-11-22T06:01:31+00:00\",\"dateModified\":\"2023-01-09T15:31:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/it\\\/2022\\\/11\\\/22\\\/new-indication-ioflupane\\\/\"},\"wordCount\":12,\"articleSection\":[\"Comunicati stampa\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/it\\\/2022\\\/11\\\/22\\\/new-indication-ioflupane\\\/\",\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/it\\\/2022\\\/11\\\/22\\\/new-indication-ioflupane\\\/\",\"name\":\"Curium Announces New Indication for Ioflupane I 123 Injection in the U.S. - Curium Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#website\"},\"datePublished\":\"2022-11-22T06:01:31+00:00\",\"dateModified\":\"2023-01-09T15:31:28+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#\\\/schema\\\/person\\\/e4f8faf9cb0b0abf9a175f21afe353c6\"},\"description\":\"Curium intends to submit updated labeling to the FDA for its generic version of DaTscan\u2122 (Ioflupane I 123 Injection) to include a new indication and updated safety information.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/it\\\/2022\\\/11\\\/22\\\/new-indication-ioflupane\\\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.curiumpharma.com\\\/it\\\/2022\\\/11\\\/22\\\/new-indication-ioflupane\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/it\\\/2022\\\/11\\\/22\\\/new-indication-ioflupane\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.curiumpharma.com\\\/it\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Curium Announces New Indication for Ioflupane I 123 Injection in the U.S.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/\",\"name\":\"Curium Pharma\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.curiumpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.curiumpharma.com\\\/#\\\/schema\\\/person\\\/e4f8faf9cb0b0abf9a175f21afe353c6\",\"name\":\"Elisabeth Baucells\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/33b8a272bd481f1f7e7f35ba80eadfdcbbc3bd405b0dce428b88ffe41082b8c7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/33b8a272bd481f1f7e7f35ba80eadfdcbbc3bd405b0dce428b88ffe41082b8c7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/33b8a272bd481f1f7e7f35ba80eadfdcbbc3bd405b0dce428b88ffe41082b8c7?s=96&d=mm&r=g\",\"caption\":\"Elisabeth Baucells\"},\"url\":\"https:\\\/\\\/www.curiumpharma.com\\\/it\\\/author\\\/elisabeth-baucellscuriumpharma-com\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Curium Announces New Indication for Ioflupane I 123 Injection in the U.S. - Curium Pharma","description":"Curium intends to submit updated labeling to the FDA for its generic version of DaTscan\u2122 (Ioflupane I 123 Injection) to include a new indication and updated safety information.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/","og_locale":"it_IT","og_type":"article","og_title":"Curium Announces New Indication for Ioflupane I 123 Injection in the U.S. - Curium Pharma","og_description":"Curium intends to submit updated labeling to the FDA for its generic version of DaTscan\u2122 (Ioflupane I 123 Injection) to include a new indication and updated safety information.","og_url":"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/","og_site_name":"Curium Pharma","article_published_time":"2022-11-22T06:01:31+00:00","article_modified_time":"2023-01-09T15:31:28+00:00","author":"Elisabeth Baucells","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Elisabeth Baucells"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/#article","isPartOf":{"@id":"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/"},"author":{"name":"Elisabeth Baucells","@id":"https:\/\/www.curiumpharma.com\/#\/schema\/person\/e4f8faf9cb0b0abf9a175f21afe353c6"},"headline":"Curium Announces New Indication for Ioflupane I 123 Injection in the U.S.","datePublished":"2022-11-22T06:01:31+00:00","dateModified":"2023-01-09T15:31:28+00:00","mainEntityOfPage":{"@id":"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/"},"wordCount":12,"articleSection":["Comunicati stampa"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/","url":"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/","name":"Curium Announces New Indication for Ioflupane I 123 Injection in the U.S. - Curium Pharma","isPartOf":{"@id":"https:\/\/www.curiumpharma.com\/#website"},"datePublished":"2022-11-22T06:01:31+00:00","dateModified":"2023-01-09T15:31:28+00:00","author":{"@id":"https:\/\/www.curiumpharma.com\/#\/schema\/person\/e4f8faf9cb0b0abf9a175f21afe353c6"},"description":"Curium intends to submit updated labeling to the FDA for its generic version of DaTscan\u2122 (Ioflupane I 123 Injection) to include a new indication and updated safety information.","breadcrumb":{"@id":"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.curiumpharma.com\/it\/2022\/11\/22\/new-indication-ioflupane\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.curiumpharma.com\/it\/"},{"@type":"ListItem","position":2,"name":"Curium Announces New Indication for Ioflupane I 123 Injection in the U.S."}]},{"@type":"WebSite","@id":"https:\/\/www.curiumpharma.com\/#website","url":"https:\/\/www.curiumpharma.com\/","name":"Curium Pharma","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.curiumpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Person","@id":"https:\/\/www.curiumpharma.com\/#\/schema\/person\/e4f8faf9cb0b0abf9a175f21afe353c6","name":"Elisabeth Baucells","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/secure.gravatar.com\/avatar\/33b8a272bd481f1f7e7f35ba80eadfdcbbc3bd405b0dce428b88ffe41082b8c7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/33b8a272bd481f1f7e7f35ba80eadfdcbbc3bd405b0dce428b88ffe41082b8c7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/33b8a272bd481f1f7e7f35ba80eadfdcbbc3bd405b0dce428b88ffe41082b8c7?s=96&d=mm&r=g","caption":"Elisabeth Baucells"},"url":"https:\/\/www.curiumpharma.com\/it\/author\/elisabeth-baucellscuriumpharma-com\/"}]}},"_links":{"self":[{"href":"https:\/\/www.curiumpharma.com\/it\/wp-json\/wp\/v2\/posts\/25782","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curiumpharma.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curiumpharma.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curiumpharma.com\/it\/wp-json\/wp\/v2\/users\/89"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curiumpharma.com\/it\/wp-json\/wp\/v2\/comments?post=25782"}],"version-history":[{"count":0,"href":"https:\/\/www.curiumpharma.com\/it\/wp-json\/wp\/v2\/posts\/25782\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.curiumpharma.com\/it\/wp-json\/wp\/v2\/media?parent=25782"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curiumpharma.com\/it\/wp-json\/wp\/v2\/categories?post=25782"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curiumpharma.com\/it\/wp-json\/wp\/v2\/tags?post=25782"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}